Posted on April 7, 2025
Wakefield Hospital is proud to introduce the latest in urological treatment with the SOLTIVE™ Thulium Laser – a state-of-the-art technology offering patients a safer, faster, and more effective option for managing a range of urinary conditions.
Laser surgery is a minimally invasive and highly precise method used to treat conditions such as benign prostatic hyperplasia (BPH), kidney stones, urethral strictures, and bladder tumours. Using the SOLTIVE™ Thulium Laser, our surgeons perform procedures through the urethra, eliminating the need for open surgery and significantly reducing recovery times.
Compared to traditional energy sources, the SOLTIVE laser allows:
Wakefield Hospital remains at the forefront of urological care, and we are excited to offer this advanced technology to our patients.
Today we celebrate Employee Appreciation Day and take this opportunity to acknowledge the incredible staff that help make this organisation great. Sue Channon, Evolution’s Chief Executive Officer...
Read moreBruce Bennett says new technology that zeroes in on hard-to-target prostate cancer is a great advancement – he just wishes it had arrived earlier, and cheaper. After...
Read moreAcurity Health Group and property partner Vital Healthcare Property Trust have confirmed base isolators will be employed in the $106 million re-development of Wellington’s Wakefield Hospital enabling...
Read moreBase isolators will be part of Wakefield Hospital’s $106 million redevelopment to ensure it can keep operating following a major earthquake. Plans were announced in November to bowl most...
Read more